Published in J Chromatogr on May 15, 1987
Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine. Br J Clin Pharmacol (1994) 0.77
Adverse reactions to co-trimoxazole in HIV infection. Lancet (1991) 3.16
Enoxacin raises plasma theophylline concentrations. Lancet (1984) 2.46
The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol (1986) 2.43
Enoxacin decreases the clearance of theophylline in man. Br J Clin Pharmacol (1985) 1.86
Rapid determination of amoxycillin (clamoxyl) and ampicillin (penbritin) in body fluids of many by means of high-performance liquid chromatography. J Chromatogr (1978) 1.69
Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue. J Antimicrob Chemother (1988) 1.34
Pharmacokinetics of antibiotics in critically ill patients. Intensive Care Med (1990) 1.28
High-performance liquid chromatography and preliminary pharmacokinetics of enoxacin and its 4-oxo metabolite in human plasma, urine and saliva. J Chromatogr (1985) 1.28
Early osteosynthesis and prophylactic mechanical ventilation in the multitrauma patient. J Trauma (1982) 1.21
Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in rats. Antimicrob Agents Chemother (1985) 1.13
Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. Br J Rheumatol (1994) 1.08
Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency. J Antimicrob Chemother (1979) 1.07
Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res (1986) 1.07
Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur J Clin Pharmacol (1989) 1.03
Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic? AIDS (1995) 1.02
Oxytocin and desamino-oxytocin tablets are not stable under simulated tropical conditions. J Clin Pharm Ther (1995) 1.02
The penetration of ofloxacin into lung tissue. J Antimicrob Chemother (1988) 1.01
Bioavailabilities of quercetin-3-glucoside and quercetin-4'-glucoside do not differ in humans. J Nutr (2000) 1.00
Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology. Drugs (1998) 1.00
Therapeutic monitoring of valproic acid. Ther Drug Monit (1980) 0.98
Comparison of high performance liquid chromatography and microbiological assay in the determination of plasma cefuroxime concentrations in rabbits. J Antimicrob Chemother (1980) 0.96
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline. Drugs (1987) 0.95
Pharmacokinetics of rectal diclofenac and its hydroxy metabolites in man. Int J Clin Pharmacol Ther Toxicol (1990) 0.95
Propylene glycol pharmacokinetics and effects after intravenous infusion in humans. Ther Drug Monit (1987) 0.94
Ergometrine and methylergometrine tablets are not stable under simulated tropical conditions. J Clin Pharm Ther (1995) 0.94
Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs. Vet Q (1988) 0.94
Rapid and sensitive determination of ambroxol in human plasma and urine by high-performance liquid chromatography. J Chromatogr (1987) 0.93
Clinical pharmacokinetics of sulfonamides and their metabolites: an encyclopedia. Antibiot Chemother (1971) (1987) 0.92
Excretion of amphetamines in human sweat. Arch Int Pharmacodyn Ther (1972) 0.89
Enoxacin in lower respiratory tract infections. J Antimicrob Chemother (1986) 0.89
Dosage adjustment for ceftazidime in patients with impaired renal function. Eur J Clin Pharmacol (1986) 0.89
Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole. Br J Clin Pharmacol (1994) 0.89
Convulsive effects and pharmacokinetics of laudanosine in the rat. Eur J Anaesthesiol (1986) 0.89
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man. Clin Pharmacokinet (1980) 0.88
Pharmacokinetics of baclofen in spastic patients receiving multiple oral doses. Pharm Weekbl Sci (1990) 0.88
Comparison of the pharmacokinetics of intravenously administered rac-baclofen and its (-)-(R)- and (+)-(S)-enantiomers in dogs. Int J Clin Pharmacol Res (1989) 0.87
Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis. J Antimicrob Chemother (1996) 0.87
Intravenous regional anesthesia with 0.5% articaine, 0.5% lidocaine, or 0.5% prilocaine. A double-blind randomized clinical study. Reg Anesth (1997) 0.87
Determination of trimethoprim and sulfamethoxazole (co-trimoxazole) in body fluids of man by means of high-performance liquid chromatography. J Chromatogr (1978) 0.86
Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses. Am J Vet Res (1987) 0.85
Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Br J Clin Pharmacol (1995) 0.85
Clinical pharmacokinetics of sulfonamides in children: relationship between maturing kidney function and renal clearance of sulfonamides. Ther Drug Monit (1985) 0.85
Interaction between the fluoroquinolones and the bronchodilator theophylline. J Antimicrob Chemother (1988) 0.85
Chemotherapy and pharmacokinetics of some antimicrobial agents in healthy dwarf goats and those infected with Ehrlichia phagocytophila (tick-borne fever). Res Vet Sci (1986) 0.85
In vitro antimicrobial activity of hydroxy and N4-acetyl sulphonamide metabolites. Vet Q (1985) 0.85
Simultaneous determination and pharmacokinetics of midazolam and its hydroxymetabolites in plasma and urine of man and dog by means of high-performance liquid chromatography. Arzneimittelforschung (1981) 0.84
Placental transfer and renal clearance of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in a pregnant ewe. J Vet Pharmacol Ther (1983) 0.84
Simultaneous determination of diazepam and its metabolies N-desmethyldiazepam, oxydiazepam and oxazepam in plasma and urine of man and dog by means of high-performance liquid chromatography. J Chromatogr (1979) 0.84
Non-enzymic conversion of pyruvate in aqueous solution to 2,4-dihydroxy-2-methylglutaric acid. FEBS Lett (1978) 0.83
Steady state bupivacaine plasma concentrations and safety of a femoral "3-in-1" nerve block with bupivacaine in patients over 80 years of age. Int J Clin Pharmacol Ther (2003) 0.83
Comparative pharmacokinetics, bioavailability and renal clearance of five parenteral oxytetracycline-20% formulations in dairy cows. Vet Q (1986) 0.83
Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response. Br J Clin Pharmacol (1996) 0.83
Pharmacokinetics, metabolism, and renal clearance of sulfadiazine, sulfamerazine, and sulfamethazine and of their N4-acetyl and hydroxy metabolites in calves and cows. Am J Vet Res (1988) 0.83
Influence of protein binding and severity of illness on renal elimination of four cephalosporin drugs in intensive-care patients. Pharm Weekbl Sci (1987) 0.82
Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract (2000) 0.82
Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Ann Pharmacother (1993) 0.82
Analysis of N4-trideuteroacetylsulphamerazine and its metabolites sulphamerazine and N4-acetylsulphamerazine in man by means of high-performance liquid chromatography and mass spectrometry. Biomed Mass Spectrom (1983) 0.81
[Side effects of gentamycin following implantation of PMMA containing gentamycin in the form of bead chains]. Aktuelle Probl Chir Orthop (1987) 0.81
Treatment of a patient with impaired renal function with gentamicin-PMMA-beads. Arch Orthop Trauma Surg (1981) 0.81
Pharmacokinetics and renal clearance of oxytetracycline after intravenous and intramuscular administration to dairy cows. Vet Q (1985) 0.81
Effects of acute and chronic cocaine administration on EEG and behaviour in intact and castrated male and intact and ovariectomized female rats. Brain Res Bull (1996) 0.80
Some physico-chemical properties of amphetamine and related drugs. J Pharm Pharmacol (1969) 0.80
Suppression of renal excretion of fencamfamine in man. Eur J Pharmacol (1969) 0.80
Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers. J Pharm Pharmacol (1995) 0.80
Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids. J Chromatogr (1984) 0.80
Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results. Anaesth Intensive Care (1987) 0.80
Effect of albumin distribution. A simulation analysis of the effect of altered albumin distribution on the apparent volume of distribution and apparent elimination rate constant of drugs. Pharm Weekbl Sci (1989) 0.80
Enantioselective high-performance liquid chromatographic determination of baclofen after derivatization with a chiral adduct of o-phthaldialdehyde. J Chromatogr (1987) 0.79
The efficacy and plasma disposition of chloramphenicol and spiramycin in tick-borne fever-infected dwarf goats. J Vet Pharmacol Ther (1986) 0.79
Clinical pharmacokinetics of carbenicillin, carfecillin, ticarcillin and BL-P 1654 in dairy cows. J Vet Pharmacol Ther (1984) 0.79
Effect of injection site on the bioavailability of an oxytetracycline formulation in ruminant calves. Vet Q (1983) 0.79
Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives. Antibiot Chemother (1971) (1982) 0.79
Identification in hashish of tetrahydrocannabinol, cannabidiol and cannabinol analogues with a methyl side-chain. J Pharm Pharmacol (1972) 0.79
The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. Acta Anaesthesiol Belg (1991) 0.79
The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study. Pharm Weekbl Sci (1988) 0.79
Rapid determination of 4-hydroxybutyric acid (Gamma OH) and 2-propyl pentanoate (Depakine) in human plasma be means of gas-liquid chromatography. J Chromatogr (1976) 0.79
Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes. Obstet Gynecol (1993) 0.79
Pharmacokinetics of sulphamethoxazole in calves and cows. Vet Q (1991) 0.79
Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women. Int J Clin Pharmacol Ther (1995) 0.78
Dose dependent disposition of sulphadimidine and of its N4-acetyl and hydroxy metabolites in plasma and milk of dairy cows. Vet Q (1985) 0.78
High-performance liquid chromatographic method for the determination of diclofenac and its hydroxy metabolites in human plasma and urine. J Chromatogr (1990) 0.78
Direct determination of codeine, norcodeine, morphine and normorphine with their corresponding O-glucuronide conjugates by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1991) 0.78
High-performance liquid chromatographic analysis of baclofen in plasma and urine of man after precolumn extraction and derivatization with o-phthaldialdehyde. J Chromatogr (1985) 0.78
The pharmacokinetic profile of naproxen suppository in man. Int J Clin Pharmacol Ther Toxicol (1988) 0.78
Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone. Br J Anaesth (1998) 0.78
Pharmacokinetics of a sulphamethoxazole/trimethoprim formulation in pigs after intravenous administration. Vet Q (1991) 0.78
Midazolam as a sedative on regional anesthesia. Preliminary results. Arzneimittelforschung (1981) 0.78
Pharmacokinetics: metabolism and renal excretion of quinolones in man. Pharm Weekbl Sci (1986) 0.78
Pharmacokinetics, metabolism, and renal excretion of articaine and its metabolite articainic acid in patients after epidural administration. Eur J Anaesthesiol (1989) 0.78
Rapid determination of succinylcholine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1991) 0.77
Continuous infusion of midazolam during anaesthesia and postoperative sedation after maxillofacial surgery. Acta Anaesthesiol Scand (1989) 0.77
Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites. Pharm Res (1984) 0.77
Comparison of the effects and disposition kinetics of articaine and lidocaine in 20 patients undergoing intravenous regional anaesthesia during day case surgery. Pharm World Sci (1998) 0.77
Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion. Eur J Clin Pharmacol (1981) 0.77
Pharmacokinetics of intravenously administered dantrolene and its 5-hydroxy metabolite in dogs. Int J Clin Pharmacol Res (1990) 0.77
Acetylation of sulphamethoxazole by the snail Cepaea hortensis. J Vet Pharmacol Ther (1984) 0.77
Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine. Br J Clin Pharmacol (1994) 0.77
Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function. Ther Drug Monit (1981) 0.77
The role of plasma protein binding on the metabolism and renal excretion of sulphadimethoxine and its metabolite N4-acetylsulphadimethoxine in pigs. Vet Q (1990) 0.77